T he Hippo pathway has been shown to play a critical role in controlling organ size and tumorigenesis by regulating cell proliferation. 1 The Hippo pathway was originally discovered in Drosophila and was named after the Drosophila Hippo kinase. Later genetic and biochemical studies revealed that the components of this pathway are highly conserved from flies to mammals, including mammalian sterile20-like 1/2 (Mst1/2), large tumor suppressor 1/2, and yes-associated protein (YAP). 1 Strikingly, these human components can functionally rescue the corresponding Drosophila mutants in vivo, suggesting a functional conservation of these genes. 2 In mammals, cell contact, or other unknown mechanisms, trigger Mst1/2 kinase activation with subsequent phosphorylation and activation of large tumor suppressor 1/2 kinase, which then directly phosphorylates YAP S127. 3, 4 Phosphorylated YAP binds to 14-3-3 proteins, which retain YAP in cytoplasm by hindering nuclear import, thereby inactivating YAP function. 3 Mutation of YAP serine 127 to alanine (S127A) renders YAP resistant to Hippo kinase-induced phosphorylation, resulting in an elevated YAP function. Furthermore, mutation of all 5 Lats kinase phosphorylation motifs (5SA), including S127, in YAP creates an even more powerful YAP that, unlike the YAP S127A mutant, is able to potently transform NIH-3T3 cells. 5 Unphosphorylated YAP translocates into the nucleus where it binds to a variety of transcription factors, to regulate gene expression required for control of cell proliferation, thereby promoting cell growth and oncogenic transformation. 6 In support of YAP is a potent oncoprotein; YAP is overexpressed in a spectrum of human primary tumors. 7 Taken together, these studies demonstrated that YAP plays an essential role in tumorigenesis, and YAP phosphorylation by Hippo pathway kinases is critical for regulating YAP function.
Smooth muscle cells (SMCs) are found in most hollow organs and control the involuntary contraction of these organs. Fully differentiated or mature SMCs are quiescent with little proliferation and are almost completely programmed for contraction with high expression of a unique array of contractile proteins such as SM α-actin, calponin, Hic-5, 8 SM myosin heavy chain, 130-kDa myosin light chain kinase, and SM22-α. 9 Vascular SMCs exhibit remarkable phenotypic plasticity. In response to environmental stimuli SMCs may modulate from a contractile phenotype to a proliferative and migratory phenotype (synthetic phenotype) that contributes to vascular remodeling and lesion formation. 9 Although tremendous progress has been made in defining specific transcriptional mechanisms involved in regulating SMC contractile gene expression, 10 the mechanisms that coordinate SMC contractile and synthetic phenotype switching are poorly explored.
Several studies suggest that cancer and SM-related diseases such as neointimal formation during atherosclerosis or after arterial injury share several common fundamental biological mechanisms. 11 For example, like tumor cells, after vascular injury SMCs are highly proliferative and migratory with loss of expression of differentiation markers. 9 Abnormal proliferation and migration of SMCs are the key events in atherosclerosis, neointimal hyperplasia, and in response to vascular injury. The SMC proliferation and migration are critical for early plaque development and, therefore, plaques can be considered as benign SMC tumors of the arterial wall. [11] [12] [13] Given that YAP has been demonstrated to be a potent oncoprotein to promote cell proliferation and migration, we hypothesize that YAP plays an essential role in SM phenotypic switching.
In this report, we demonstrate that expression of YAP is dramatically induced during SM phenotypic modulation to the synthetic state in vitro and in vivo. We show that YAP plays a critical role in coordinating the phenotypic modulation of SMCs, by inhibiting expression of SM differentiation genes and by promoting proliferative and migratory functions. Depletion of YAP expression after arterial injury alleviates the injuryinduced SM−specific gene downregulation and attenuates neointima formation in vivo. This study suggests that components of the Hippo−YAP pathway may be appropriate therapeutic targets for ameliorating SM-related vascular diseases.
Materials and Methods
Rat aortic SMCs were prepared as previously reported. 8 Mouse carotid artery ligation and rat carotid artery balloon injury were performed as described in our previous reports. 8, 14 A detailed Materials and Methods section is provided in the online-only Data Supplement.
Results

YAP Expression Is Induced During SM Phenotypic Modulation
To explore the potential function of YAP in SMCs, first we examined the expression of YAP during SM phenotypic modulation. During phenotypic switch of vascular SMCs induced by cell culture, YAP expression was dramatically induced in parallel with the expression of the synthetic SMC marker nonmuscle myosin heavy chain IIB, 15 whereas expression of contractile SMC markers, including SM22-α, SM α-actin, and Hic-5, was significantly reduced ( Figure IA in the online-only Data Supplement). The phosphorylated YAP (p-YAP, S127) signal was elevated as well, suggesting the YAP upstream kinase pathway was activated after vascular SMC cultured in growth medium. Furthermore, immunostaining experiments revealed that YAP primarily localized in the nuclei of cultured vascular SMCs, although consistent with the observed high levels of p-YAP by Western blot, YAP signal was also seen in cytoplasm ( Figure IB in the online-only Data Supplement). We next sought to examine YAP expression during SM phenotypic modulation in vivo. Consistent with the in vitro data, we found that YAP was significantly elevated in a rat carotid artery balloon injury model that resembles angioplasty in humans, 16 both 3 and 14 days after injury ( Figure 1A , 1B, and 1D). YAP expression coincides with increased expression of proliferative SM marker, proliferating cell nuclear antigen ( Figure 1B) , and downregulation of SM contractile genes ( Figure 1A and 1B) . Similarly, elevated YAP expression was observed 3, 7, and 21 days after mouse carotid ligation injury that is characterized by phenotypic modulation of medial SMCs, 17 as indicated by the data from quantitative real-time polymerase chain reaction (qRT-PCR), Western blot, and immunohistological staining assays ( Figure IIA −IIC in the online-only Data Supplement). In contrast, genes for SM contractile phenotype, including SM α-actin, Hic-5, and SM22α, were significantly reduced ( Figure  IIB in the online-only Data Supplement). In agreement with a previous study showing that arterial injury can induce and activate Mst1, 18 an upstream Hippo kinase of YAP, we found balloon injury increases p-YAP level ( Figure 1B ). However, total YAP expression increased significantly more than the p-YAP signal as the percentage of YAP phosphorylated after injury actually decreased by 50% ( Figure 1C ). Consistent with this finding, immunohistochemical staining demonstrated that YAP is highly expressed in the synthetic neointima SMCs where it is localized in the nuclei of ≈50% of the SMCs ( Figure 2D and 2E). Furthermore, the expression YAP was significantly increased in the nuclear fractions from balloon-injured carotid arteries ( Figure III in the online-only Data Supplement). These data suggested that the excessive induction of YAP can override the phosphorylation-induced repression of YAP mediated by upstream Hippo pathway kinases, suggesting a feedback regulatory loop. Taken together, these in vitro and in vivo data demonstrate that YAP expression and nuclear localization is positively correlated with the synthetic SM phenotype.
YAP Represses Smooth Muscle-Specific Gene Expression
As YAP expression is significantly induced during SM phenotypic modulation in vitro and in vivo, we then sought to investigate the function of YAP in regulating expression of SM-specific genes by gain-or loss-of-function assays. Retrovirus encoding wild-type (WT) YAP, constitutively active YAP 5SA, or empty control vector were transduced into rat aortic SMCs. We first performed phalloidin staining to examine the effects of overexpression of YAP and 5SA on SMC cytoskeleton organization. Data from this experiment demonstrated that overexpression WT YAP and YAP 5SA displayed dramatic cell morphological alteration. Moreover, cells expressing YAP 5SA lost cell-cell contact inhibition and grow on top of each other ( Figure IV in the online-only Data Supplement). To further characterize YAP functions in SMCs, protein or RNA from rat aortic SMCs that were transduced by WT YAP, YAP 5SA, or empty control vector were harvested and SM gene expression quantitated by Western blotting and quantitative real-time polymerase chain reaction. All SM-specific genes examined were significantly downregulated 50% to 90% by overexpression of WT YAP or the 5SA YAP mutant at both the protein and mRNA level (Figure 2A and 2B). The YAP 5SA mutant, which is resistant to inhibition induced by the Hippo pathway, was more potent in abrogating SM-specific gene expression compared with WT YAP (Figure 2A and 2B). Moreover, data from reporter assays revealed that WT YAP or YAP 5SA significantly inhibit SM-specific Hic-5 and SM myosin heavy chain promoter activity ( Figure 2C ), suggesting the inhibitory effect on SM-specific gene expression by WT YAP or 5SA mutant YAP is at the transcriptional level. Consistently, depletion of YAP using short interfering RNA significantly increased expression of SM markers in rat aortic SMCs ( Figure 2D and 2E) . Finally, overexpression YAP or YAP 5SA strongly induced the expression of cyclin D1, a cell cycle−regulating gene that was previously shown to promote cell proliferation 19 ( Figure 2A ), whereas knockdown YAP significantly downregulated cyclin D1 expression at both protein and mRNA levels in cultured vascular SMCs ( Figure 2D and 2E) . Silencing YAP has no effects on the expression of serum response factor (SRF), a key regulator for SM differentiation. 20 Together, these data demonstrate that YAP is a potent repressor for SM-specific gene expression, whereas YAP is a strong inducer for cell proliferation gene expression.
YAP Promotes SMC Proliferation
Proliferation of vascular SMCs plays a key role in the development of neointima thickening. Because YAP is induced in cell culture and after arterial injury where modulated SMCs are known to be proliferative and migratory, we directly tested whether YAP is able to affect SMC proliferation by overexpressing YAP or 5SA mutant in rat aortic SMCs ( Figure 3A and 3B) and silencing endogenous YAP with short interfering RNA ( Figure 3C and 3D) . Data from these experiments revealed that the rates of SMC proliferation were stimulated by YAP overexpression while inhibited by silencing endogenous YAP expression, supporting a positive role for the YAP in regulating vascular SMC proliferation.
YAP Promotes SMC Migration
In response to arterial injury SMC migration from medial layer is another key event to build neointima. Using a scratch wound healing assay, we found that overexpression of YAP in rat aortic SMCs significantly promotes wound closure that is known to be dependent primarily on cell migration over this time period (Figure 4A and 4B) . Boyden chamber assays further confirmed that YAP can promote SMC migration, whereas 5SA mutant has a stronger effect ( Figure 4C ). In contrast, silencing endogenous YAP impaired wound closure ( Figure 4D ), suggesting that YAP plays an important role in SMC migration.
Knockdown or Knockout of YAP In Vivo Prevents Arterial Injury-Induced SM Phenotypic Modulation and Attenuates Neointima Formation
We next sought to determine the role of YAP in SM phenotypic modulation and neointima hyperplasia in vivo by transduction with lentivirus encoding short hairpin (sh) RNA against YAP (shYAP) to attenuate YAP gene upregulation after rat carotid artery balloon injury. We first confirmed that shYAP lentivirus efficiently knocked down expression of YAP in vitro ( Figure VA in the online-only Data Supplement) and that the lentivirus efficiently transduced into the injured vascular wall after arterial injury ( Figure VB in the online-only Data Supplement). Short hairpin luciferase lentivirus-transduced animals served as controls. We chose D14 postinjury to assess the effects of silencing YAP on SM gene expression and neointima formation, as previous study has shown that the highest SMC fraction within neointima was seen at this time point. 16 Data from Western blotting and immunostaining revealed that in vivo knockdown of YAP after rat carotid balloon injury significantly rescued injury-induced downregulation of SM-specific genes ( Figure 5A and 5B), including the most restricted SM marker, SM myosin heavy chain ( Figure Taken together, these data demonstrated that blocking YAP induction after rat carotid artery balloon injury can reduce the arterial injury-induced decrease in expression of SM-specific genes and attenuate neointima formation by inhibiting SMC proliferation. To further determine the specific contribution of SMC-derived YAP on neointima formation, a carotid artery ligation injury was performed on SMC-specific YAP heterozygote knockout mice. For these experiments, we could not use homozygous SMC-specific YAP knockout mice as they die perinatally (data not shown). First, we demonstrated that YAP expression in SMC-specific YAP heterozygotes (SM22α-Cre
, YAP SM Het) was reduced in SMCs by 50%, with no change of expression in other non-SM tissues, such as brain ( Figure VIII in the online-only Data Supplement). Twenty-one days after ligation injury there was an attenuated reduction of SM-specific gene expression and decreased SMC proliferation in YAP heterozygous mice ( Figure 6A ). This resulted in a 40% to 50% decrease in neointima formation in the SM-specific heterozygote YAP mice ( Figure 6B-6D) . Taken together, these data demonstrated that inactivation of YAP within SMCs is sufficient to upregulate SM-specific gene expression and attenuate neointima formation after arterial ligation injury.
Discussion
The Hippo signaling pathway is evolutionarily conserved from Drosophila to mammals and plays a critical role in controlling Figure 3 . Yes-associated protein (YAP) promotes smooth muscle cell (SMC) proliferation. A, Retrovirus encoding wild-type or 5 Lats kinase phosphorylation motifs (5SA) mutant YAP or empty vector were transduced into cultured rat aortic SMCs, and then proliferation was measured using a cell proliferation WST-1 kit (Roche) in the different culture medium as indicated. *P<0.05. B, Virus-transduced rat aortic SMCs were plated at equal density in 10% FBS medium, and then cells were collected and counted at each time point as indicated. *P<0.05. C, Control or YAP silencing duplex were transfected into rat aortic SMCs, and cell proliferation was measured using a WST-1 kit or cells were counted at each time point as described above (D). *P<0.05. PDGF-BB indicates platelet-derived growth factor-BB.
Figure 4.
Yes-associated protein (YAP) promotes smooth muscle cell (SMC) migration. A, Rat aortic SMCs transduced with retrovirus encoding YAP or control vector were seeded in 6-well plates at confluent density. Cell migration was assayed 8 or 12 hours after scratching a wound across the cell monolayer, and the relative closure distance was measured (B). The gap distance in vector control cells was normalized and set to 1. Data presented are mean±SE for 2 independent experiments with 5 independent fields counted in each experiment. C, Quantification of Boyden chamber assay to assess cell migration after a 5-hour plating of virus-transduced rat aortic SMCs. The cell numbers of control vector group were set to 1. D, Control or YAP silencing duplex were transfected into rat aortic SMCs overnight, and the wound healing assay was performed to measure cell migration. The closure distance was measured 12 hours after wounding and plotted as described in A and B. *P<0.05. 5SA indicates 5 Lats kinase phosphorylation motifs. organ size and tumorigenesis by regulating cell proliferation. 1 In this report, we demonstrated that YAP plays a novel role in vascular SMCs. We found that overexpression of YAP promotes SMC migration and proliferation while attenuating SM contractile gene expression (Figures 2-4) . Conversely, knocking down endogenous YAP in SMCs upregulates SM-specific gene expression while attenuating SMC proliferation and migration (Figures 2-4 ) in vitro. During the preparation of the manuscript, we noticed that a recent study showed similar results demonstrating that the YAP is induced upon stimuli of SM phenotypic modulation and knockdown YAP can increase SM-specific gene expression in vitro. 21 However, this study was performed in cell culture settings, whereas YAP function in vascular SMCs in vivo is completely unknown. In the current report, we provide the first evidence demonstrating that knocking down YAP expression in vivo in rats and mice is sufficient to prevent vascular injury-induced decreases in SM-specific genes and attenuates neointima formation (Figures 5 and 6) .
YAP 5SA, a mutant that is insensitive to Hippo inhibition, more dramatically abrogated SM gene expression in vitro and had a stronger ability to promote SMC proliferation and migration (Figures 2-4) . Furthermore, arterial injury and cell culture activates the endogenous Hippo kinase cascade to inactivate a portion of YAP by retaining it in the cytoplasm ( Figure I in the online-only Data Supplement and Figure 1 ). This activated Hippo signaling can thus be viewed as a natural protective response to the detrimental stimuli to prevent excessive SMC proliferation and lesion formation. Although, both cell culture and arterial injury stimulate activation of YAP upstream kinases to phosphorylate and inactivate YAP, the excessive induction of total YAP expression overwhelms this regulatory system resulting in unphospholylated YAP translocating into the SMC nuclei. This nuclear YAP promotes SMC migration and proliferation while inhibiting SM differentiation by attenuating SM-specific gene expression. In support of the notion that the Hippo pathway plays a critical role in the vasculature after injury, a previous study showed that arterial injury induces and activates Mst1 kinase and infection with adenovirusencoding Mst1 in balloon-injured rat carotid artery suppressed neointimal formation. 18 Additionally, cardiac-specific deletion of Mst kinase-associated activator salvador, or deletion of Hippo kinases Mst1/2 and large tumor suppressor 1/2 in mouse, led to activated YAP, resulting in large hearts with elevated cardiomyocyte proliferation. 22 Although the endogenous ligands stimulating this pathway are poorly characterized in mammals, one recognized stimulus is cell contact, a stimulus that is known to activate Hippo kinases but negatively affect SMC proliferation and promote differentiation. 23, 24 Taken together, these studies suggested that Hippo signaling is crucial for regulating YAP function in cardiomyocytes and vascular SMCs. Although our data showed that YAP phosphorylation is elevated during SM phenotypic modulation, it is unknown Figure 5 . Knockdown yes-associated protein (YAP) after rat carotid artery balloon injury rescues smooth muscle phenotypic switch and attenuates neointima formation. A, Fourteen days after injury, rat control or balloon-injured carotid arteries infected with either shLuci or YAP short hairpin RNA (shYAP) lentivirus during injury were harvested for Western blotting. B, Quantification of protein expression in A from 3 independent injury experiments. Expression was normalized to loading control GAPDH then expressed relative to its corresponding uninjured control artery (set to 1, red line). n=3. *P<0.05. C, Hematoxylin-eosin staining of carotid artery sections from either control or balloon-injured vessels that were transduced with shLuciferase (shLuci), or shYAP lentivirus during injury. Tissues were harvested 14 days postinjury. The internal elastic lamina is highlighted in yellow. Scale bar, 100 μm. D, Statistical analysis of neointima/media layer ratio and relative neointima area (E) in C using ImageJ software. n=4. *P<0.05. MLCK, indicates myosin light chain kinase.
which Hippo signaling components are involved in this process. Future studies are needed to explore the precise mechanisms by which the Hippo pathway is activated in response to arterial injury and screen the stimuli that are involved in YAP induction during SM phenotypic modulation.
It is interesting to speculate on how YAP may promote SM cell proliferation while inhibiting differentiation. YAP lacks a DNA-binding domain but functions as a potent transcriptional cofactor through interaction with TEA domain transcription factors (TEAD) or PPxY (PY)-motif containing transcription factors via its N-terminal TEADbinding domain or through a C terminus WW domain, respectively. 6 Both TEAD-binding domain and WW domains have been shown to be required for YAP-mediated oncogenic activity. 25 For instance, TEAD-binding element within cyclin D1 gene promoter is crucial for YAP-mediated malignant mesothelioma cell proliferation. 19 Consistent with this, we found cylcin D1 is significantly induced by overexpression YAP whereas knockdown of YAP decreases cyclin D1 expression, suggesting the positive effects of YAP on SMC proliferation are at least partially through induction of cell cycle-regulating genes. Previous studies have also shown that TEAD-binding elements within the SM α-actin promoter, that bind TEAD proteins, are required for activity of the promoter in embryonic SMCs but not in adult SMCs. 26, 27 TEAD1 has also been shown to directly interact with SRF, 28,29 a transcription factor required for expression of most SM-specific genes. 20 SRF also plays an important role in regulating SMC migration and proliferation by interaction with a variety of cofactors. 30 The Hippo pathway may, thus, regulate expression of SM-specific genes and affect SM proliferation and migration through modulating the activity of SRF. Further studies are needed to investigate this possibility. Furthermore, YAP also physically and functionally interacts with PY motif-containing transcription factors, such as SMAD7, p73, Runx1, and Runx2, through its WW domain. 6 Interestingly, we also identified a conserved PY motif in the myocardin family proteins (data not shown), a group of factors that are potent activators of SM-specific genes through interaction with SRF. 30 Consistent with this, YAP can interact with myocardin and disrupt myocardin binding to SRF, thereby downregulating SM-specific gene expression. 21 Together these findings suggest that YAP may regulate the phenotype of vascular SMCs by altering the activity of the SRF axis. Additionally, it has been shown that transforming growth factor-β and Notch signaling are involved in the SM differentiation 9, 31 ; further investigation is needed to test the possible cross talk between Hippo-YAP pathway with transforming growth factor-β and Notch signaling.
Elucidating the mechanisms controlling SM phenotypic modulation is critical for understanding the pathogenesis and progression of many vascular diseases and ultimately identifying new therapeutic targets to treat these diseases. A number of serious clinical conditions, including atherosclerosis, intimal hyperplasia associated with restenosis, and vein graft stenosis, are largely dependent upon SMC phenotype modulation contributing to progression of intimal lesions, resulting in occlusions of vessels. 9 These phenotypically switched SMCs in the neointima, in turn, exacerbate lesion development by increasing production of growth factors and extracellular matrix. 32 In this report. we demonstrate that preventing YAP induction after arterial injury can significantly attenuate neointima formation in vivo at least in part through inhibiting SMC proliferation and migration (Figures 5 and 6 ). As neointimal formation after arterial injury includes multiple cellular processes, such as SMC death, matrix production, and endothelial regeneration, it will be intriguing to investigate whether YAP can affect these aspects. In summary, this exciting study not only provides completely novel insights into the mechanisms controlling SMC phenotypic modulation but also identifies YAP as a potential therapeutic target for ameliorating vascular diseases.
